Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and "depressed" mice exposed to chronic mild stress

Neuroscience

Volumn 290, Issue , 2015, Pages 49-60

  Franceschelli, A ^a   Sens, J ^a   Herchick, S ^a   Thelen, C ^a   Pitychoutis, P M ^a  

^a UNIVERSITY OF DAYTON   (United States)

Author keywords

Antidepressant; Chronic mild stress; Forced swim test; Gender; Glutamate; Ketamine

Indexed keywords

ASPARTIC ACID; GLUTAMIC ACID; KETAMINE; ANTIDEPRESSANT AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SEROTONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; ASPARTIC ACID TISSUE LEVEL; BEHAVIOR CHANGE; CHRONIC STRESS; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE INCREASE; FEMALE; FORCED SWIM TEST; GLUTAMIC ACID TISSUE LEVEL; HIPPOCAMPUS; LOW DRUG DOSE; MAJOR DEPRESSION; MALE; MENTAL STRESS; MOUSE; NEUROCHEMISTRY; NONHUMAN; OPEN FIELD TEST; PREFRONTAL CORTEX; SEROTONINERGIC SYSTEM; SEX DIFFERENCE; SINGLE DRUG DOSE; TISSUE LEVEL; TREATMENT RESPONSE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CHRONIC DISEASE; DEPRESSIVE DISORDER; DISEASE MODEL; DRUG EFFECTS; EXPLORATORY BEHAVIOR; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SEXUAL DEVELOPMENT; SWIMMING; TIME;

ANIMALS; ANTIDEPRESSIVE AGENTS; ASPARTIC ACID; CHRONIC DISEASE; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; FEMALE; GLUTAMIC ACID; HIPPOCAMPUS; KETAMINE; MALE; MICE, INBRED C57BL; PREFRONTAL CORTEX; RECEPTORS, N-METHYL-D-ASPARTATE; SEROTONIN; SEX CHARACTERISTICS; STRESS, PSYCHOLOGICAL; SWIMMING; TIME FACTORS;

EID: 84922341384     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.01.008     Document Type: Article

References (60)

1. Adachi M., Barrot M., Autry A.E., Theobald D., Monteggia L.M. Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol Psychiatry 2008, 63:642-649.
2. Anderson I.M., Juhasz G., Thomas E., Downey D., McKie S., Deakin J.F., Elliott R. The effect of acute citalopram on face emotion processing in remitted depression: a pharmacoMRI study. Eur Neuropsychopharmacol 2011, 21:140-148.
3. Autry A.E., Adachi M., Nosyreva E., Na E.S., Los M.F., Cheng P.F., Kavalali E.T., Monteggia L.M. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 2011, 475:91-95.
4. Bechtholt-Gompf A.J., Smith K.L., John C.S., Kang H.H., Carlezon W.A., Cohen B.M., Ongur D. CD-1 and Balb/cJ mice do not show enduring antidepressant-like effects of ketamine in tests of acute antidepressant efficacy. Psychopharmacology (Berl) 2011, 215:689-695.
5. Beery A.K., Zucker I. Sex bias in neuroscience and biomedical research. Neurosci Biobehav Rev 2011, 35:565-572.
6. Browne C.A., Lucki I. Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants. Front Pharmacol 2013, 4:161.
7. Carballedo A., Scheuerecker J., Meisenzahl E., Schoepf V., Bokde A., Moller H.J., Doyle M., Wiesmann M., Frodl T. Functional connectivity of emotional processing in depression. J Affect Disord 2011, 134:272-279.
8. Carrier N., Kabbaj M. Sex differences in the antidepressant-like effects of ketamine. Neuropharmacology 2013, 70:27-34.
9. Celada P., Puig M., Amargos-Bosch M., Adell A., Artigas F. The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci 2004, 29:252-265.
10. Chatterjee M., Verma R., Ganguly S., Palit G. Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in mice. Neuropharmacology 2012, 63:1161-1171.
11. Collins P.Y., Patel V., Joestl S.S., March D., Insel T.R., Daar A.S., Anderson W., Dhansay M.A., Phillips A., Shurin S., Walport M., Ewart W., Savill S.J., Bordin I.A., Costello E.J., Durkin M., Fairburn C., Glass R.I., Hall W., Huang Y., et al. Grand challenges in global mental health. Nature 2011, 475:27-30.
12. Commissiong J.W. Monoamine metabolites: their relationship and lack of relationship to monoaminergic neuronal activity. Biochem Pharmacol 1985, 34:1127-1131.
13. Cryan J.F., Markou A., Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 2002, 23:238-245.
14. Curras M.C., Dingledine R. Selectivity of amino acid transmitters acting at N-methyl-d-aspartate and amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors. Mol Pharmacol 1992, 41:520-526.
15. Dalla C., Pitychoutis P.M., Kokras N., Papadopoulou-Daifoti Z. Sex differences in response to stress and expression of depressive-like behaviours in the rat. Curr Top Behav Neurosci 2011, 8:97-118.
16. Deacon R.M. Digging and marble burying in mice: simple methods for in vivo identification of biological impacts. Nat Protoc 2006, 1:122-124.
17. Donzanti B.A., Yamamoto B.K. An improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates. Life Sci 1988, 43:913-922.
18. Drevets W.C. Orbitofrontal cortex function and structure in depression. Ann N Y Acad Sci 2007, 1121:499-527.
19. Duman R.S. Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections. Dialogues Clin Neurosci 2014, 16:11-27.
20. Duman R.S., Li N., Liu R.J., Duric V., Aghajanian G. Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 2012, 62:35-41.
21. Elhwuegi A.S. Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:435-451.
22. Elizalde N., Garcia-Garcia A.L., Totterdell S., Gendive N., Venzala E., Ramirez M.J., Del Rio J., Tordera R.M. Sustained stress-induced changes in mice as a model for chronic depression. Psychopharmacology (Berl) 2010, 210:393-406.
23. Elizalde N., Gil-Bea F.J., Ramirez M.J., Aisa B., Lasheras B., Del Rio J., Tordera R.M. Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: effect of antidepressant treatment. Psychopharmacology (Berl) 2008, 199:1-14.
24. Engin E., Treit D., Dickson C.T. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models. Neuroscience 2009, 161:359-369.
25. Franceschelli A., Herchick S., Thelen C., Papadopoulou-Daifoti Z., Pitychoutis P.M. Sex differences in the chronic mild stress model of depression. Behav Pharmacol 2014, 25:372-383.
26. Garcia L.S., Comim C.M., Valvassori S.S., Reus G.Z., Andreazza A.C., Stertz L., Fries G.R., Gavioli E.C., Kapczinski F., Quevedo J. Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels. Basic Clin Pharmacol Toxicol 2008, 103:502-506.
27. Garcia L.S., Comim C.M., Valvassori S.S., Reus G.Z., Stertz L., Kapczinski F., Gavioli E.C., Quevedo J. Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:450-455.
28. Gigliucci V., O'Dowd G., Casey S., Egan D., Gibney S., Harkin A. Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism. Psychopharmacology (Berl) 2013, 228:157-166.
29. Golembiowska K., Dziubina A. Effect of acute and chronic administration of citalopram on glutamate and aspartate release in the rat prefrontal cortex. Pol J Pharmacol 2000, 52:441-448.
30. Greenspan J.D., Craft R.M., LeResche L., Arendt-Nielsen L., Berkley K.J., Fillingim R.B., Gold M.S., Holdcroft A., Lautenbacher S., Mayer E.A., Mogil J.S., Murphy A.Z., Traub R.J. Studying sex and gender differences in pain and analgesia: a consensus report. Pain 2007, 132(Suppl 1):S26-45.
31. Grigoriadis S., Robinson G.E. Gender issues in depression. Ann Clin Psychiatry 2007, 19:247-255.
32. Groenewegen H.J., Uylings H.B. The prefrontal cortex and the integration of sensory, limbic and autonomic information. Prog Brain Res 2000, 126:3-28.
33. Holden C. Sex and the suffering brain. Science 2005, 308:1574.
34. Kavalali E.T., Monteggia L.M. Synaptic mechanisms underlying rapid antidepressant action of ketamine. Am J Psychiatry 2012, 169:1150-1156.
35. Kokras N., Antoniou K., Polissidis A., Papadopoulou-Daifoti Z. Antidepressants induce regionally discrete, sex-dependent changes in brain's glutamate content. Neurosci Lett 2009, 464:98-102.
36. Li N., Lee B., Liu R.J., Banasr M., Dwyer J.M., Iwata M., Li X.Y., Aghajanian G., Duman R.S. MTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010, 329:959-964.
37. Li N., Liu R.J., Dwyer J.M., Banasr M., Lee B., Son H., Li X.Y., Aghajanian G., Duman R.S. Glutamate N-methyl-d-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry 2011, 69:754-761.
38. Lindholm J.S., Autio H., Vesa L., Antila H., Lindemann L., Hoener M.C., Skolnick P., Rantamaki T., Castren E. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf(+)/(-) heterozygous null mice. Neuropharmacology 2012, 62:391-397.
39. Lorrain D.S., Baccei C.S., Bristow L.J., Anderson J.J., Varney M.A. Effects of ketamine and N-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience 2003, 117:697-706.
40. Ma X.C., Dang Y.H., Jia M., Ma R., Wang F., Wu J., Gao C.G., Hashimoto K. Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice. PLoS One 2013, 8:e56053.
41. Maeng S., Zarate C.A., Du J., Schloesser R.J., McCammon J., Chen G., Manji H.K. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 2008, 63:349-352.
42. Marcus S.M., Young E.A., Kerber K.B., Kornstein S., Farabaugh A.H., Mitchell J., Wisniewski S.R., Balasubramani G.K., Trivedi M.H., Rush A.J. Gender differences in depression: findings from the STAR*D study. J Affect Disord 2005, 87:141-150.
43. McCarthy M.M., Arnold A.P., Ball G.F., Blaustein J.D., De Vries G.J. Sex differences in the brain: the not so inconvenient truth. J Neurosci 2012, 32:2241-2247.
44. Muller H.K., Wegener G., Liebenberg N., Zarate C.A., Popoli M., Elfving B. Ketamine regulates the presynaptic release machinery in the hippocampus. J Psychiatr Res 2013, 47:892-899.
45. Nishitani N., Nagayasu K., Asaoka N., Yamashiro M., Shirakawa H., Nakagawa T., Kaneko S. Raphe AMPA receptors and nicotinic acetylcholine receptors mediate ketamine-induced serotonin release in the rat prefrontal cortex. Int J Neuropsychopharmacol 2014, 17:1321-1326.
46. Nollet M., Le Guisquet A.M., Belzung C. Models of depression: unpredictable chronic mild stress in mice. Curr Protoc Pharmacol 2013, Chapter 5. [Unit 5.65].
47. Pitychoutis P.M., Dalla C., Sideris A.C., Tsonis P.A., Papadopoulou-Daifoti Z. 5-HT(1A), 5-HT(2A), and 5-HT(2C) receptor mRNA modulation by antidepressant treatment in the chronic mild stress model of depression: sex differences exposed. Neuroscience 2012, 210:152-167.
48. Pitychoutis P.M., Pallis E.G., Mikail H.G., Papadopoulou-Daifoti Z. Individual differences in novelty-seeking predict differential responses to chronic antidepressant treatment through sex- and phenotype-dependent neurochemical signatures. Behav Brain Res 2011, 223:154-168.
49. Pitychoutis P.M., Zisaki A., Dalla C., Papadopoulou-Daifoti Z. Pharmacogenetic insights into depression and antidepressant response: does sex matter?. Curr Pharm Des 2010, 16:2214-2223.
50. Pozzi L., Pollak Dorocic I., Wang X., Carlen M., Meletis K. Mice lacking NMDA receptors in parvalbumin neurons display normal depression-related behavior and response to antidepressant action of NMDAR antagonists. PLoS One 2014, 9:e83879.
51. Rezin G.T., Goncalves C.L., Daufenbach J.F., Fraga D.B., Santos P.M., Ferreira G.K., Hermani F.V., Comim C.M., Quevedo J., Streck E.L. Acute administration of ketamine reverses the inhibition of mitochondrial respiratory chain induced by chronic mild stress. Brain Res Bull 2009, 79:418-421.
52. Silvestre J.S., Nadal R., Pallares M., Ferre N. Acute effects of ketamine in the holeboard, the elevated-plus maze, and the social interaction test in Wistar rats. Depress Anxiety 1997, 5:29-33.
53. Skolnick P., Popik P., Trullas R. Glutamate-based antidepressants: 20 years on. Trends Pharmacol Sci 2009, 30:563-569.
54. Sloan D.M., Kornstein S.G. Gender differences in depression and response to antidepressant treatment. Psychiatr Clin North Am 2003, 26:581-594.
55. Stratinaki M., Varidaki A., Mitsi V., Ghose S., Magida J., Dias C., Russo S.J., Vialou V., Caldarone B.J., Tamminga C.A., Nestler E.J., Zachariou V. Regulator of G protein signaling 4 [corrected] is a crucial modulator of antidepressant drug action in depression and neuropathic pain models. Proc Natl Acad Sci U S A 2013, 110:8254-8259.
56. Thomas A., Burant A., Bui N., Graham D., Yuva-Paylor L.A., Paylor R. Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacology (Berl) 2009, 204:361-373.
57. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl) 1997, 134:319-329.
58. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52:90-110.
59. Yamanaka H., Yokoyama C., Mizuma H., Kurai S., Finnema S.J., Halldin C. Doi H, Onoe H A possible mechanism of the nucleus accumbens and ventral pallidum 5-HT1B receptors underlying the antidepressant action of ketamine: a PET study with macaques. Transl Psychiatry 2014, 4:e342.
60. Young E.A., Kornstein S.G., Marcus S.M., Harvey A.T., Warden D., Wisniewski S.R., Balasubramani G.K., Fava M., Trivedi M.H., John Rush A. Sex differences in response to citalopram: a STAR*D report. J Psychiatr Res 2009, 43:503-511.